Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The gut microbiome and allograft outcomes: implications for heart transplantation
Ivan Ðuran, W.H. Wilson Tang, Petra Mamic
Ivan Ðuran, W.H. Wilson Tang, Petra Mamic
View: Text | PDF
Review

The gut microbiome and allograft outcomes: implications for heart transplantation

  • Text
  • PDF
Abstract

Heart transplantation remains the gold standard therapy for patients with end-stage heart failure. However, post-transplant complications are considerable. Emerging evidence implicates the gut microbiome as a modifiable determinant of post–heart transplant outcomes through its influence on host immunity, metabolism, and inflammation. This Review synthesizes current understanding of gut microbiome dysregulation following solid organ transplantation, with particular emphasis on heart transplantation, examining mechanistic links underpinning important complications including allograft rejection, infection, metabolic dysfunction, and cardiac allograft vasculopathy. We critically evaluate bidirectional interactions between the gut microbiome and immunosuppressive drugs, assess the potential for microbiome profiling to serve as a predictive biomarker for post-transplant complications, and examine microbiome-targeted interventions including dietary modification, prebiotics, probiotics, and fecal microbiota transplant. Finally, we propose a translational roadmap to integrate microbiome science into heart transplant care to optimize immunosuppression, predict complications, and improve long-term outcomes for heart transplant recipients.

Authors

Ivan Ðuran, W.H. Wilson Tang, Petra Mamic

×

Figure 3

The mechanisms of gut microbiome modulation of alloimmunity and post-transplant rejection risk.

Options: View larger image (or click on image) Download as PowerPoint
The mechanisms of gut microbiome modulation of alloimmunity and post-tra...
(A) A tolerogenic environment is promoted by high-fiber diet and downstream production of SCFAs like acetate and butyrate by the gut microbiome. Acetate and butyrate promote Treg differentiation. Butyrate additionally stimulates regulatory B cells and suppresses pro-inflammatory responses by inhibiting histone deacetylase in macrophages. Beneficial bacteria, such as Bifidobacterium and Alistipes, support immune tolerance by enhancing Treg function, increasing antiinflammatory cytokines (IL-10, TGF-β), and reducing pro-inflammatory cytokines (TNF-α, IL-6). Select probiotics can further induce Tregs. (B) Increased rejection risk is related to heightened inflammatory tone associated with pro-inflammatory microbes such as Desulfovibrio, which increases inflammatory cytokines while suppressing Tregs and antiinflammatory IL-10. Unhealthy dietary habits, such as a high-salt diet, can inhibit protective bacteria, leading to the expansion of pro-inflammatory Th17 cells. High-fat diet is also associated with heightened T cell stimulation and increased rejection risk. Full lines indicate host effects demonstrated in transplant models, with colors signifying protective (green) or detrimental (red) alloimmune effects. Arrows represent stimulatory, and blunt-ended lines inhibitory, relationships. Organ icons refer to the transplanted organ (heart, kidney, skin, or aorta). Dotted lines represent immune effects demonstrated in nontransplant models, of potential relevance for alloimmunity.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts